Advertisement

Interventions to Influence Opioid Prescribing Practices for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis

Published:November 20, 2020DOI:https://doi.org/10.1016/j.amepre.2020.07.012

      Context

      This study is a systematic review of interventions to improve adherence to guideline recommendations for prescribing opioids for chronic noncancer pain.

      Evidence acquisition

      Investigators searched CINAHL, Embase, MEDLINE, PsycINFO, the Cochrane Library, and Joanna Briggs Institute Evid Based Pract database from inception until June 3, 2019. Interventional studies to improve adherence to recommendations made by opioid guidelines for chronic noncancer pain in North America were eligible if outcomes included adherence to guideline recommendations or change in quantity of opioids prescribed. Data were extracted independently and in duplicate. Quantitative synthesis was performed using random effects meta-analysis. Confidence in evidence was determined using the Grades of Recommendation, Assessment, Development, and Evaluation.

      Evidence synthesis

      A total of 20 studies (8 controlled and 12 prospective cohort) involving 1,491 providers and 72 clinics met inclusion. Interventions included education, audit and feedback, interprofessional support, shared decision making, and multifaceted strategies. Multifaceted interventions improved the use of urine drug testing (n=2, or =2.31, 95% CI=1.53, 3.49, z=3.98, p<0.01; high-certainty evidence), treatment agreements (n=2, or =1.96, 95% CI=1.47, 2.61, z=4.56, p<0.01; moderate-certainty evidence), and mental health screening (n=2, 2.57-fold, 95% CI=1.56, 4.24, z=2.32, p=0.02; low-certainty evidence) when prescribing opioids for chronic noncancer pain. Very low–certainty evidence suggests that several interventions improved the use of treatment agreements, urine drug testing, and prescription drug monitoring programs.

      Conclusions

      Mostly very low–certainty evidence supports a number of interventions for improving adherence to risk management strategies when prescribing opioids for chronic noncancer pain; however, the effect on patient important outcomes (e.g., overdose, addiction, death) is uncertain.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Nelson LS
        • Juurlink DN
        • Perrone J
        Addressing the opioid epidemic.
        JAMA. 2015; 314: 1453-1454
        • Compton WM
        • Jones CM
        • Baldwin GT
        Relationship between nonmedical prescription-opioid use and heroin use.
        N Engl J Med. 2016; 374: 154-163
        • Juurlink DN
        • Dhalla IA
        Dependence and addiction during chronic opioid therapy.
        J Med Toxicol. 2012; 8: 393-399
        • Busse JW
        • Wang L
        • Kamaleldin M
        • et al.
        Opioids for chronic noncancer pain: a systematic review and meta-analysis.
        JAMA. 2018; 320: 2448-2460
        • Lee M
        • Silverman SM
        • Hansen H
        • Patel VB
        • Manchikanti L
        A comprehensive review of opioid-induced hyperalgesia.
        Pain Physician. 2011; 14: 145-161
        • Chou R
        • Turner JA
        • Devine EB
        • et al.
        The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop.
        Ann Intern Med. 2015; 162: 276-286
        • Gomes T
        • Mamdani MM
        • Dhalla IA
        • Cornish S
        • Paterson JM
        • Juurlink DN
        The burden of premature opioid-related mortality.
        Addiction. 2014; 109: 1482-1488
        • Gomes T
        • Tadrous M
        • Mamdani MM
        • Paterson JM
        • Juurlink DN
        The burden of opioid-related mortality in the United States.
        JAMA Netw Open. 2018; 1e180217
        • Vowles KE
        • McEntee ML
        • Julnes PS
        • Frohe T
        • Ney JP
        • van der Goes DN
        Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis.
        Pain. 2015; 156: 569-576
        • Dowell D
        • Haegerich TM
        • Chou R
        CDC guideline for prescribing opioids for chronic pain—United States, 2016.
        JAMA. 2016; 315: 1624-1645
        • Busse JW
        • Craigie S
        • Juurlink DN
        • et al.
        Guideline for opioid therapy and chronic noncancer pain.
        CMAJ. 2017; 189: E659-E666
        • Nuckols TK
        • Anderson L
        • Popescu I
        • et al.
        Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain.
        Ann Intern Med. 2014; 160: 38-47
        • Tournebize J
        • Gibaja V
        • Muszczak A
        • Kahn JP
        Are physicians safely prescribing opioids for chronic noncancer pain? A systematic review of current evidence.
        Pain Pract. 2016; 16: 370-383
        • Hossain MA
        • Asamoah-Boaheng M
        • Badejo OA
        • et al.
        Prescriber adherence to guideline recommendations for opioids to manage chronic non-cancer pain: a systematic review and meta-analysis.
        Health Psychol. 2020; 39: 430-451
        • Rash JA
        • Buckley N
        • Busse JW
        • et al.
        Healthcare provider knowledge, attitudes, beliefs, and practices surrounding the prescription of opioids for chronic non-cancer pain in North America: protocol for a mixed-method systematic review.
        Syst Rev. 2018; 7: 189
        • McGowan J
        • Sampson M
        • Salzwedel DM
        • Cogo E
        • Foerster V
        • Lefebvre C
        PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement.
        J Clin Epidemiol. 2016; 75: 40-46
        • Chou R
        • Fanciullo GJ
        • Fine PG
        • et al.
        Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.
        J Pain. 2009; 10: 113-130
        • Manchikanti L
        • Kaye AM
        • Knezevic NN
        • et al.
        Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) guidelines.
        Pain Physician. 2017; 20: S3-S92
        • Schechter NL
        • Walco GA
        The potential impact on children of the CDC guideline for prescribing opioids for chronic pain: above all, do no harm.
        JAMA Pediatr. 2016; 170: 425-426
        • Fischer B
        • Keates A
        • Bühringer G
        • Reimer J
        • Rehm J
        Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world.
        Addiction. 2014; 109: 177-181
        • Ouzzani M
        • Hammady H
        • Fedorowicz Z
        • Elmagarmid A
        Rayyan-a web and mobile app for systematic reviews.
        Syst Rev. 2016; 5: 210
        • Akl EA
        • Sun X
        • Busse JW
        • et al.
        Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid.
        J Clin Epidemiol. 2012; 65: 262-267
        • Higgins JP
        • Altman DG
        • Gøtzsche PC
        • et al.
        The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
        BMJ. 2011; 343: d5928
        • Moola S
        • Munn Z
        • Tufanaru C
        • et al.
        Chapter 7: Systematic reviews of etiology and risk.
        in: Aromataris EM Munn Z JBI Manual for Evidence Synthesis. JBI, Adelaide, Australia2020
        • Lipsey MW
        • Wilson DB
        Practical Meta-Analysis.
        SAGE Publications, Inc., Thousand Oaks, CA2001
        • Liebschutz JM
        • Xuan Z
        • Shanahan CW
        • et al.
        Improving adherence to long-term opioid therapy guidelines to reduce opioid misuse in primary care: a cluster-randomized clinical trial.
        JAMA Intern Med. 2017; 177: 1265-1272
        • DerSimonian R
        • Laird N
        Meta-analysis in clinical trials.
        Control Clin Trials. 1986; 7: 177-188
        • Higgins JP
        • Thompson SG
        Quantifying heterogeneity in a meta-analysis.
        Stat Med. 2002; 21: 1539-1558
        • Orwin RG
        A fail-safe N for effect size in meta-analysis.
        J Educ Stat. 1983; 8: 157-159
      1. Schünemann H Brożek J Guyatt G Oxman A GRADE Handbook: Handbook for Grading the Quality of Evidence and the Strength of Recommendations Using the GRADE Approach. Cochrane Collaboration, London, United Kingdom2013
        • Corson K
        • Doak MN
        • Denneson L
        • et al.
        Primary care clinician adherence to guidelines for the management of chronic musculoskeletal pain: results from the study of the effectiveness of a collaborative approach to pain.
        Pain Med. 2011; 12: 1490-1501
        • Midmer D
        • Kahan M
        • Marlow B
        Effects of a distance learning program on physicians’ opioid- and benzodiazepine-prescribing skills.
        J Contin Educ Health Prof. 2006; 26: 294-301
        • Quanbeck A
        • Brown RT
        • Zgierska AE
        • et al.
        A randomized matched-pairs study of feasibility, acceptability, and effectiveness of systems consultation: a novel implementation strategy for adopting clinical guidelines for opioid prescribing in primary care.
        Implement Sci. 2018; 13: 21
        • Sullivan MD
        • Leigh J
        • Gaster B
        Brief report: training internists in shared decision making about chronic opioid treatment for noncancer pain.
        J Gen Intern Med. 2006; 21: 360-362
        • Trudeau KJ
        • Hildebrand C
        • Garg P
        • Chiauzzi E
        • Zacharoff KL
        A randomized controlled trial of the effects of online pain management education on primary care providers.
        Pain Med. 2017; 18: 680-692
        • Anderson D
        • Zlateva I
        • Davis B
        • et al.
        Improving pain care with Project ECHO in community health centers.
        Pain Med. 2017; 18: 1882-1889
        • Purcell N
        • Zamora K
        • Tighe J
        • Li Y
        • Douraghi M
        • Seal K
        The Integrated Pain Team: a mixed-methods evaluation of the impact of an embedded interdisciplinary pain care intervention on primary care team satisfaction, confidence, and perceptions of care effectiveness.
        Pain Med. 2018; 19: 1748-1763
        • Alford DP
        • Zisblatt L
        • Ng P
        • et al.
        SCOPE of pain: an evaluation of an opioid risk evaluation and mitigation strategy continuing education program.
        Pain Med. 2016; 17: 52-63
        • Anderson DR
        • Zlateva I
        • Coman EN
        • Khatri K
        • Tian T
        • Kerns RD
        Improving pain care through implementation of the Stepped Care Model at a multisite community health center.
        J Pain Res. 2016; 9: 1021-1029
        • Brown J
        • Setnik B
        • Lee K
        • et al.
        Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting.
        J Opioid Manag. 2011; 7: 467-483
        • Canada RE
        • DiRocco D
        • Day S
        A better approach to opioid prescribing in primary care.
        J Fam Pract. 2014; 63: E1-E8
        • Chen JH
        • Hom J
        • Richman I
        • Asch SM
        • Podchiyska T
        • Johansen NA
        Effect of opioid prescribing guidelines in primary care.
        Medicine (Baltimore). 2016; 95: e4760
        • Cox N
        • Tak CR
        • Cochella SE
        • Leishman E
        • Gunning K
        Impact of pharmacist previsit input to providers on chronic opioid prescribing safety.
        J Am Board Fam Med. 2018; 31: 105-112
        • Downes JM
        • Klepser DG
        • Foster J
        • Nelson M
        Development of a standardized approach for managing opioids in adults with chronic noncancer pain.
        Am J Health Syst Pharm. 2018; 75: 321-326
        • Jacobs SC
        • Son EK
        • Tat C
        • Chiao P
        • Dulay M
        • Ludwig A
        Implementing an opioid risk assessment telephone clinic: outcomes from a pharmacist-led initiative in a large Veterans Health Administration primary care clinic, December 15, 2014-March 31, 2015.
        Subst Abus. 2016; 37: 15-19
        • Westanmo A
        • Marshall P
        • Jones E
        • Burns K
        • Krebs EE
        Opioid dose reduction in a VA Health Care System–implementation of a primary care population-level initiative.
        Pain Med. 2015; 16: 1019-1026
        • Zaman T
        • Rife TL
        • Batki SL
        • Pennington DL
        An electronic intervention to improve safety for pain patients co-prescribed chronic opioids and benzodiazepines.
        Subst Abus. 2018; 39: 441-448
        • Zisblatt L
        • Hayes SM
        • Lazure P
        • Hardesty I
        • White JL
        • Alford DP
        Safe and competent opioid prescribing education: increasing dissemination with a train-the-trainer program.
        Subst Abus. 2017; 38: 168-176
        • Larson MJ
        • Browne C
        • Nikitin RV
        • et al.
        Physicians report adopting safer opioid prescribing behaviors after academic detailing intervention.
        Subst Abus. 2018; 39: 218-224
        • Forsetlund L
        • Bjørndal A
        • Rashidian A
        • et al.
        Continuing education meetings and workshops: effects on professional practice and health care outcomes.
        Cochrane Database Syst Rev. 2009; 2009CD003030
        • O'Brien MA
        • Rogers S
        • Jamtvedt G
        • et al.
        Educational outreach visits: effects on professional practice and health care outcomes.
        Cochrane Database Syst Rev. 2007; 2007CD000409
        • Flodgren G
        • Parmelli E
        • Doumit G
        • et al.
        Local opinion leaders: effects on professional practice and health care outcomes.
        Cochrane Database Syst Rev. 2011; CD000125
        • Ivers N
        • Jamtvedt G
        • Flottorp S
        • et al.
        Audit and feedback: effects on professional practice and healthcare outcomes.
        Cochrane Database Syst Rev. 2012; CD000259
        • Volkow ND
        • McLellan TA
        Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment.
        JAMA. 2011; 305: 1346-1347
        • Edlund MJ
        • Austen MA
        • Sullivan MD
        • et al.
        Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011.
        Pain. 2014; 155: 2337-2343
        • Gallagher R
        • Hatcher L
        Will the new opioid guidelines harm more people than they help? Yes.
        Can Fam Physician. 2018; 64: 101-102
        • Starrels JL
        • Becker WC
        • Alford DP
        • Kapoor A
        • Williams AR
        • Turner BJ
        Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain.
        Ann Intern Med. 2010; 152: 712-720
        • Ebbert JO
        • Philpot LM
        • Clements CM
        • et al.
        Attitudes, beliefs, practices, and concerns among clinicians prescribing opioids in a large academic institution.
        Pain Med. 2018; 19: 1790-1798
        • Franklin GM
        • Fulton-Kehoe D
        • Turner JA
        • Sullivan MD
        • Wickizer TM
        Changes in opioid prescribing for chronic pain in Washington State.
        J Am Board Fam Med. 2013; 26: 394-400
        • Kahan M
        • Dubin R
        • Clarke H
        The 2017 Canadian opioid guideline: already time for an overhaul.
        CMAJ. 2018; 190: E300
        • Krebs EE
        • Bergman AA
        • Coffing JM
        • Campbell SR
        • Frankel RM
        • Matthias MS
        Barriers to guideline-concordant opioid management in primary care–a qualitative study.
        J Pain. 2014; 15: 1148-1155
        • Lavoie KL
        • Rash JA
        • Campbell TS
        Changing provider behavior in the context of chronic disease management: focus on clinical inertia.
        Annu Rev Pharmacol Toxicol. 2017; 57: 263-283
        • Boutron I
        • Moher D
        • Altman DG
        • Schulz KF
        • Ravaud P
        • CONSORT Group
        Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
        Ann Intern Med. 2008; 148: 295-309
        • Gellad WF
        • Good CB
        • Shulkin DJ
        Addressing the opioid epidemic in the United States: lessons from the Department of Veterans Affairs.
        JAMA Intern Med. 2017; 177: 611-612
        • Penm J
        • MacKinnon NJ
        • Boone JM
        • Ciaccia A
        • McNamee C
        • Winstanley EL
        Strategies and policies to address the opioid epidemic: a case study of Ohio.
        J Am Pharm Assoc (2003). 2017; 57: S148-S153
        • Haffajee RL
        • Jena AB
        • Weiner SG
        Mandatory use of prescription drug monitoring programs.
        JAMA. 2015; 313: 891-892
        • Czajkowski SM
        • Powell LH
        • Adler N
        • et al.
        From ideas to efficacy: the ORBIT model for developing behavioral treatments for chronic diseases.
        Health Psychol. 2015; 34: 971-982